VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 456 filers reported holding VALEANT PHARMACEUTICALS INTL in Q1 2014. The put-call ratio across all filers is 0.78 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $91,799,000 | -18.1% | 413,232 | -26.8% | 9.50% | -9.2% |
| Q1 2015 | $112,068,000 | +32.0% | 564,232 | -4.9% | 10.47% | +37.8% |
| Q4 2014 | $84,897,000 | -0.2% | 593,232 | -8.5% | 7.60% | -8.4% |
| Q3 2014 | $85,091,000 | -42.1% | 648,561 | -44.3% | 8.29% | -24.5% |
| Q2 2014 | $146,955,000 | +30.7% | 1,165,200 | +36.6% | 10.98% | +4.6% |
| Q1 2014 | $112,477,000 | +3.3% | 853,200 | -8.0% | 10.50% | +11.4% |
| Q4 2013 | $108,853,000 | -5.1% | 927,200 | -15.7% | 9.42% | -21.3% |
| Q3 2013 | $114,711,000 | +17.7% | 1,099,500 | -2.9% | 11.97% | +17.0% |
| Q2 2013 | $97,486,000 | – | 1,132,500 | – | 10.23% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |